# A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence

> **NCT00749632** · PHASE2 · COMPLETED · sponsor: **FemmePharma Global Healthcare, Inc.** · enrollment: 45 (actual)

## Conditions studied

- Urinary Incontinence, Urge

## Interventions

- **DRUG:** oxybutynin
- **DRUG:** oxybutynin
- **DRUG:** oxybutynin

## Key facts

- **NCT ID:** NCT00749632
- **Lead sponsor:** FemmePharma Global Healthcare, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2009-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00749632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00749632, "A Study of Oxybutynin for the Treatment of Urge Urinary Incontinence". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00749632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*